BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17461992)

  • 1. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
    Mullane K; Toor AA; Kalnicky C; Rodriguez T; Klein J; Stiff P
    Transpl Infect Dis; 2007 Jun; 9(2):89-96. PubMed ID: 17461992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation.
    Gupta S; Almyroudis NG; Battiwalla M; Bambach BJ; McCarthy PL; Proefrock AD; Ball D; Paplham P; Varma A; Kwon-Chung J; Segal BH
    Transpl Infect Dis; 2007 Jun; 9(2):156-60. PubMed ID: 17462004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.
    Chaftari AM; Hachem RY; Ramos E; Kassis C; Campo M; Jiang Y; Prince RA; Wang W; Raad II
    Transplantation; 2012 Aug; 94(3):302-8. PubMed ID: 22814329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
    Vehreschild JJ; Krüger K; Kurzai O; Wickenhauser C; Behringer K; Töx U; Cornely OA
    Mycoses; 2006; 49 Suppl 1():42-7. PubMed ID: 16961582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.
    Lebeau O; Van Delden C; Garbino J; Robert J; Lamoth F; Passweg J; Chalandon Y
    Transpl Infect Dis; 2010 Jun; 12(3):269-72. PubMed ID: 20163567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
    Winston DJ; Bartoni K; Territo MC; Schiller GJ
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):507-15. PubMed ID: 20460163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
    Krishna G; Martinho M; Chandrasekar P; Ullmann AJ; Patino H
    Pharmacotherapy; 2007 Dec; 27(12):1627-36. PubMed ID: 18041883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
    Raad II; Hachem RY; Herbrecht R; Graybill JR; Hare R; Corcoran G; Kontoyiannis DP
    Clin Infect Dis; 2006 May; 42(10):1398-403. PubMed ID: 16619151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The latest data on posaconazole].
    Paugam A
    Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Clark NM; Grim SA; Lynch JP
    Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
    Kubiak DW; Koo S; Hammond SP; Armand P; Baden LR; Antin JH; Marty FM
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1462-5. PubMed ID: 22564264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature.
    Lekakis LJ; Lawson A; Prante J; Ribes J; Davis GJ; Monohan G; Baraboutis IG; Skoutelis AT; Howard DS
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):991-5. PubMed ID: 19589489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Groll AH; Walsh TJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
    Nagappan V; Deresinski S
    Clin Infect Dis; 2007 Dec; 45(12):1610-7. PubMed ID: 18190324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.
    Xu SX; Shen JL; Tang XF; Feng B
    Transplant Proc; 2013; 45(1):407-14. PubMed ID: 23375330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.